Instituto de Investigación Sanitaria Gregorio Marañón-ko ikertzaileekin lankidetzan egindako argitalpenak (13)

2023

  1. Exercise facility availability and incidence of type 2 diabetes and complications in Spain: A population-based retrospective cohort 2015–2018

    Health and Place, Vol. 81

2022

  1. Implementation of an enhanced recovery after surgery program including a patient school: Impact on quality of life results

    Injury, Vol. 53, Núm. 12, pp. 3987-3992

  2. Medication guide for the perioperative management of oral antineoplastic agents in cancer patients

    Expert Opinion on Drug Safety, Vol. 21, Núm. 1, pp. 107-119

2021

  1. Are we overdosing parenteral metamizole?

    Cirugia Espanola, Vol. 99, Núm. 1, pp. 68-70

  2. Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study

    Infectious Diseases and Therapy, Vol. 10, Núm. 1, pp. 347-362

2020

  1. Improving surgical antibiotic prophylaxis adherence and reducing hospital readmissions: A bundle of interventions including health information technologies

    European Journal of Hospital Pharmacy, Vol. 27, Núm. 4, pp. 237-242

  2. Novel mobile application for direct communication between pharmacists and patients treated with oral antineoplastic agents

    American Journal of Health-System Pharmacy, Vol. 77, Núm. 17, pp. 1393-1402

2019

  1. 3D printing designs and applications in a pharmacy department

    European Journal of Clinical Pharmacy, Vol. 21, Núm. 1, pp. 13-18

  2. Evolution of nutritional status and survival in patients with cancer on tyrosine kinase inhibitors treatment

    Endocrinologia, Diabetes y Nutricion, Vol. 66, Núm. 8, pp. 472-479

2017

  1. Improving pharmacotherapy outcomes in patients with hepatitis C virus infection treated with direct-acting antivirals: The GRUviC project

    International Journal of Clinical Practice, Vol. 71, Núm. 8

2016

  1. Effectiveness and Safety of Ombitasvir-Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin for HCV Genotype 1 Infection for 12 Weeks Under Routine Clinical Practice

    Annals of Pharmacotherapy, Vol. 50, Núm. 11, pp. 901-908

  2. Guiding pharmacist clinical interviews: A safety tool to support the education of patients treated with oral antineoplastic agents

    Expert Opinion on Drug Safety, Vol. 15, Núm. 4, pp. 427-435

2015

  1. Ingesta dietética y estado nutricional de pacientes oncológicos que inician tratamiento con inhibidores tirosina quinasa

    Nutricion Hospitalaria, Vol. 32, Núm. 3, pp. 1200-1207